Browse Title Index


 
Issue Title
 
Vol 23, No 4 (2016) Negative predictive value of preoperative computed tomography in determining pathologic local invasion, nodal disease, and abdominal metastases in gastric cancer Abstract   PDF   HTML
D.J. Kagedan, F. Frankul, A. El-Sedfy, C. McGregor, M. Elmi, B. Zagorski, M.E. Dixon, A.L. Mahar, J. Vasilevska-Ristovska, L. Helyer, C. Rowsell, C.J. Swallow, C.H. Law, N.G. Coburn
 
Vol 21, No 1 (2014) Neoadjuvant endocrine treatment for breast cancer: from bedside to bench and back again? Abstract   PDF   HTML
R.R. Saleh, N. Bouganim, J. Hilton, A. Arnaout, M. Clemons
 
Vol 19, No 3 (2012) Neoadjuvant erlotinib and surgical resection of a stage IIIA papillary adenocarcinoma of the lung with an L861Q activating EGFR mutation Abstract   PDF   HTML
M. Ong, K. Kwan, S. Kamel-Reid, M. David Vincent
 
Vol 24, No 5 (2017) Neoadjuvant systemic therapy in breast cancer: use and trends in radiotherapy practice Abstract   PDF   HTML
T.A. Koulis, K. Beecham, C. Speers, S. Tyldesley, D. Voduc, C. Simmons, R. Olson
 
Vol 25, No 5 (2018) Neoadjuvant therapy for breast cancer: updates and proceedings from the Seventh Annual Meeting of the Canadian Consortium for Locally Advanced Breast Cancer Abstract   PDF   HTML
A. Arnaout, J. Lee, K. Gelmon, B. Poirier, F. I. Lu, M. Akra, J. F. Boileau, K. Tonkin, H. Li, C. Illman, C. Simmons, D. Grenier
 
Vol 25, No 2 (2018) Neutrophil–lymphocyte ratio predicts response to chemotherapy in triple-negative breast cancer Abstract   PDF   HTML
S. Chae, K.M. Kang, H.J. Kim, E. Kang, S.Y. Park, J.H. Kim, S.H. Kim, S.W. Kim, E.K. Kim
 
Vol 20, No 2 (2013) New chart review data validates administrative data- based indicator for guideline-recommended treatment of locally advanced non-small cell lung cancer and shed light on reasons for non-referral and non-treatment Abstract   PDF   HTML
J. Klein–Geltink, T. Forte, R. Rahal, G. Darling, W. Cheung, R. Alvi, G. Noonan, C. Russell, K. Vriends, J. Niu, G. Lockwood, H. Bryant
 
Vol 14, No 1 (2007) New Multidisciplinary Prostate Bone Metastases Clinic---First of its Kind in Canada Abstract   PDF
Philiz Goh, Kristin Harris, Julie Napolskikh, Edward Chow, Emily Sinclair, Urban Emmenegger, Sharon Lemon, Albert Yee, Lesia Wynnychuk, Jeff Myers, Cyril Danjoux, Yoo-Joung Ko
 
Vol 24, No 6 (2017) No evidence of excessive cancer screening in female noncarriers from BRCA1/2 mutation–positive families Abstract   PDF   HTML
S. Guedaoura, S. Pelletier, W.D. Foulkes, P. Hamet, J. Simard, N. Wong, Z. El Haffaf, J. Chiquette, M. Dorval
 
Vol 16, No 4 (2009) Non-adenomatous non-epithelial carcinoma (hemangiopericytoma) of prostate treated with conservative surgery followed by adjuvant chemoradiation Details   PDF
Bikramjit Chakrabarti, Sajal Kumar Ghosh, Suman Ghorai, Bishan Basu, Phalguni Gupta, Suparna Ghosh Ray, Chaitparna Das
 
Vol 21, No 3 (2014) Non-myeloablative allogeneic hematopoietic transplantation for patients with hematologic malignancies: 9-year single-centre experience Abstract   PDF   HTML
N.I. AlJohani, K. Thompson, W. Hasegawa, D. White, A. Kew, S. Couban
 
Vol 22, No 4 (2015) Nonsurgical treatment of recurrent glioblastoma Abstract   PDF   HTML
O. Gallego
 
Vol 22, No 1 (2015) Novel agents and associated toxicities of inhibitors of the pi3k/Akt/mtor pathway for the treatment of breast cancer Abstract   PDF   HTML
S. Chia, S. Gandhi, A.A. Joy, S. Edwards, M. Gorr, S. Hopkins, J. Kondejewski, J.P. Ayoub, N. Califaretti, D. Rayson, S. Dent
 
Vol 16, No 3 (2009) Novel developments in angiogenesis cancer therapy Details   PDF
Hal W Hirte
 
Vol 20, No 4 (2013) Nutrition and exercise interventions for patients with lung cancer appear beneficial, but more studies are required Abstract   PDF   HTML
N. Kiss, E. Isenring
 
Vol 18, No 3 (2011) O. Harold Warwick: Canada’s first medical oncologist Abstract   PDF   HTML
D. H. Cowan
 
Vol 19, No 4 (2012) Occult cause of paraneoplastic acanthosis nigricans in a patient with known breast dcis: case and review Abstract   PDF   HTML
B. D. Jakubovic, H. F. Sawires, D. N. Adam
 
Vol 25, No 3 (2018) Ode to my Oncologist Abstract   PDF   HTML
C.A. Heykoop
 
Vol 20, No 5 (2013) Oncofertility in Canada: an overview of Canadian practice and suggested action plan Abstract   PDF   HTML
R. Ronn, H.E.G. Holzer
 
Vol 21, No 1 (2014) Oncofertility in Canada: cryopreservation and alternative options for future parenthood Abstract   PDF   HTML
R. Ronn, H.E.G. Holzer
 
Vol 20, No 6 (2013) Oncofertility in Canada: gonadal protection and fertility-sparing strategies Abstract   PDF   HTML
R. Ronn, H.E.G. Holzer
 
Vol 20, No 4 (2013) Oncofertility in Canada: the impact of cancer on fertility Abstract   PDF   HTML
R. Ronn, H.E.G. Holzer
 
Vol 22, No 6 (2015) Oncologist heal thyself: hallmarks of happiness Abstract   PDF   HTML
C. Jacobs, M. Clemons, A.A. Joy
 
Vol 26, No 1 (2019) Oncology Association of Naturopathic Physicians: Principles of Care Guidelines Abstract   PDF   HTML
E. Marsden, G. Nigh, S. Birdsall, H. Wright, M. Traub
 
Vol 25, No 6 (2018) Oncology communities of practice: insights from a qualitative analysis Abstract   PDF   HTML
W. Fingrut, L. A. Beck, D. Lo
 
Vol 25, No 3 (2018) Oncology education for Canadian internal medicine residents: the value of participating in a medical oncology elective rotation Abstract   PDF   HTML
N.A. Nixon, H. Lim, C. Elser, Y.J. Ko, R. Lee-Ying, V.C. Tam
 
Vol 25, No 3 (2018) Oncology education for internal medicine residents: a call for action! Abstract   PDF   HTML
T. Younis, B. Colwell
 
Vol 21, No 1 (2014) Oncology education in Canadian undergraduate and postgraduate medical programs: a survey of educators and learners Abstract   PDF   HTML
V.C. Tam, S. Berry, T. Hsu, S. North, A. Neville, K. Chan, S. Verma
 
Vol 22, No 3 (2015) Ondansetron rapidly dissolving film for the prophylactic treatment of radiation-induced nausea and vomiting—a pilot study Abstract   PDF   HTML
E. Wong, N. Pulenzas, G. Bedard, C. DeAngelis, L. Zhang, M. Tsao, C. Danjoux, N. Thavarajah, B. Lechner, R. McDonald, P.M. Cheon, E. Chow
 
Vol 21, No 3 (2014) One compared with two cycles of mitomycin C in chemoradiotherapy for anal cancer: analysis of outcomes and toxicity Abstract   PDF   HTML
R. Yeung, Y. McConnell, G. Roxin, R. Banerjee, G.B. Roldán Urgoiti, A.R. MacLean, W.D. Buie, K.E. Mulder, M.M. Vickers, K.J. Joseph, C.M. Doll
 
Vol 17, No 2 (2010) One year of complete clinical response in a metastatic breast cancer patient treated with a combination of lapatinib and gemcitabine Abstract   PDF
J. M. Gasent Blesa, J. B. Laforga Canales, V. Alberola Candel
 
Vol 25, No 5 (2018) Only if you view it through a different lens Abstract   PDF   HTML
A. Abusanad
 
Vol 20, No 3 (2013) Opportunistic salpingectomy: the way forward—response to Steven Narod Abstract   PDF   HTML
D.M. Miller, J.N. McAlpine, C.B. Gilks, D.G. Huntsman
 
Vol 25, No 5 (2018) Opportunity is the greatest barrier to providing palliative care to advanced colorectal cancer patients: a survey of oncology clinicians Abstract   PDF   HTML   Supplemental Material
M. A. Earp, A. Sinnarajah, M. Kerba, P. A. Tang, J. Rodriquez-Arguello, S. King, S. M. Watanabe, J. E. Simon
 
Vol 14, No 5 (2007) Optimal Chemotherapy Treatment for Women with Recurrent Ovarian Cancer Details   PDF
Michael Fung-Kee-Fung, Thomas Oliver, Laurie Elit, Holger W Hirte, Peter Bryson
 
Vol 19, No 4 (2012) Optimal prophylactic and definitive therapy for bicalutamide-induced gynecomastia: results of a meta-analysis Abstract   PDF   HTML
M. A. Tunio, M. Al-Asiri, A. Al-Amro, Y. Bayoumi, M. Fareed
 
Vol 22 (2015): Updated Guidelines, Consensus and Evidence-Based Reports in Breast Cancer Optimal systemic therapy for early breast cancer in women: a clinical practice guideline Abstract   PDF   HTML
A. Eisen, G.G. Fletcher, S. Gandhi, M. Mates, O.C. Freedman, S.F. Dent, M.E. Trudeau, members of the Early Breast Cancer Systemic Therapy Consensus Panel
 
Vol 16, No 3 (2009) Optimal use of taxanes in metastatic breast cancer Abstract   PDF
Karen M King, Sasha Lupichuk, Lubna Baig, Marc Webster, Sanraj Basi, Darlene Whyte, Serena Rix
 
Vol 21, No 5 (2014) Optimism about breakthroughs in the age of targeted therapy: the Canadian Lung Cancer Conference 2014; Vancouver, British Columbia; February 7, 2014 Abstract   PDF   HTML
B. Melosky, C. Ho
 
Vol 21, No 1 (2014) Optimizing outcomes with azacitidine: recommendations from Canadian centres of excellence Abstract   PDF   HTML
R.A. Wells, B. Leber, N.Y. Zhu, J.M. Storring
 
Vol 16, No 4 (2009) Optimizing the management of advanced non-small-cell lung cancer: a personal view Abstract   PDF
Mark D. Vincent
 
Vol 17, No 4 (2010) Optimizing the management of HER2-positive early breast cancer: the clinical reality Abstract   PDF
Su. Verma, S. Lavasani, J. Mackey, K. Pritchard, M. Clemons, S. Dent, J. Latreille, J. Lemieux, L. Provencher, Sh. Verma, S. Chia, B. Wang, D. Rayson
 
Vol 25, No 4 (2018) Optimizing vascular access for patients receiving intravenous systemic therapy for early-stage breast cancer—a survey of oncology nurses and physicians Abstract   PDF   Supplemental Material   HTML
N. LeVasseur, C. Stober, K. Daigle, A. Robinson, S. McDiarmid, S. Mazzarello, B. Hutton, A. Joy, D. Fergusson, J. Hilton, M. McInnes, M. Clemons
 
Vol 24, No 4 (2017) Oral Chinese herbal medicine as maintenance treatment after chemotherapy for advanced non-small-cell lung cancer: a systematic review and meta-analysis Abstract   PDF   HTML
Q. Wang, Q. Wang, S.F. Wang, L.J. Jiao, R.X. Zhang, Y. Zhong, J. Zhang, L. Xu
 
Vol 24, No 6 (2017) Orbital mass as first presentation of metastatic p16-positive oropharyngeal squamous cell carcinoma Abstract   PDF   HTML
J. Corbett, D. Wilke, J. Trites, N. Lamond
 
Vol 23 (2016): Original Cancer Costing Research Using Canadian Data Original Canadian cancer costing research for cancer control sustainability, quality, and value Abstract   PDF   HTML
H. Bryant
 
Vol 21, No 3 (2014) Ottawa Cardiac Oncology Program wins 2013 Cancer Quality Council of Ontario Innovation Award Abstract   PDF   HTML
J. Sulpher, C. Johnson, M. Turek, A. Law, E. Stadnick, S. Hopkins, N. Graham, S.F. Dent
 
Vol 22 (2015): Updated Guidelines, Consensus and Evidence-Based Reports in Breast Cancer Outcome of patients with pregnancy during or after breast cancer: a review of the recent literature Abstract   PDF   HTML
J. Raphael, M.E. Trudeau, K. Chan
 
Vol 25, No 6 (2018) Outcomes by treatment modality in elderly patients with localized gastric and esophageal cancer Abstract   PDF   HTML
A. Natori, B. A. Chan, H. W. Sim, L. Ma, D. W. Yokom, E. Chen, G. Liu, G. Darling, C. Swallow, S. Brar, J. Brierley, J. Ringash, R. Wong, J. Kim, P. Rogalla, S. Hafezi-Bakhtiari, J. Conner, J. Knox, E. Elimova, R. W. Jang
 
Vol 19, No 4 (2012) Outcomes of accelerated hypofractionated radiotherapy in stage I non-small-cell lung cancer Abstract   PDF   HTML
T. Yung, M. E. Giuliani, L. W. Le, A. Sun, B.C.J. Cho, A. Bezjak, A. Brade, A. J. Hope
 
Vol 20, No 6 (2013) Outcomes of her2-positive early-stage breast cancer in the trastuzumab era: a population-based study of Canadian patients Abstract   PDF   HTML
U. Zurawska, D.A. Baribeau, S. Giilck, C. Victor, S. Gandhi, A. Florescu, S. Verma
 
Vol 19, No 3 (2012) Outcomes of surveillance for contralateral breast cancer in patients less than age 60 at the time of initial diagnosis Abstract   PDF   HTML
C. Weinstock, R. Bigenwald, T. Hochman, P. Sun, S.A. Narod, E. Warner
 
Vol 19, No 4 (2012) Outcomes of women with early-stage breast cancer receiving adjuvant trastuzumab Abstract   PDF   HTML
M. D. Seal, C. H. Speers, S. O'Reilly, K. A. Gelmon, S. L. Ellard, S. K. Chia
 
Vol 24, No 2 (2017) Ovarian cancer in Manitoba: trends in incidence and survival, 1992–2011 Abstract   PDF   HTML
P. Lambert, K. Galloway, A. Altman, M.W. Nachtigal, D. Turner
 
Vol 24, No 6 (2017) Ovarian function after chemotherapy in young breast cancer survivors Abstract   PDF   HTML
K. Morarji, O. McArdle, K. Hui, G. Gingras-Hill, S. Ahmed, E.M. Greenblatt, E. Warner, S. Sridhar, A.M.F. Ali, A. Azad, D.C. Hodgson
 
Vol 20, No 2 (2013) Overall survival should be the primary endpoint in clinical trials for advanced non-small cell lung cancer Abstract   PDF   HTML
P.K. Cheema, R.L. Burkes
 
Vol 25 (2018): Advances in Breast and Lung Cancers for the Community Oncologist Overcoming endocrine resistance in hormone receptor–positive breast cancer Abstract   PDF   HTML
A. AlFakeeh, C. Brezden-Masley
 
Vol 25, No 3 (2018) Overcoming resistance in a BRAF V600E–mutant adenocarcinoma of the lung Abstract   PDF   HTML
T. Schmid, M. Buess
 
Vol 22, No 1 (2015) Overdiagnosis in breast cancer chemoprevention trials Abstract   PDF   HTML
V. Sopik, S.A. Narod
 
Vol 25, No 2 (2018) Overwhelming research and clinical evidence of exercise medicine efficacy in cancer management—translation into practice is the challenge before us Abstract   PDF   HTML
R.U. Newton
 
Vol 18, No 1 (2011) Oxaliplatin: a review in the era of molecularly targeted therapy Abstract   PDF   HTML
T. Alcindor, N. Beauger
 
Vol 19 (2012): Oncology in China Oxidative DNA damage of lymphocytes in peripheral blood and ascites in cancer patients Abstract   PDF   HTML
J. Wang, S. S. Xing, S. B. Guo, W. Jin, W. Zhang
 
Vol 20, No 4 (2013) Pain assessment during conscious sedation for cervical cancer high-dose-rate brachytherapy Abstract   PDF   HTML
H. Bhanabhai, R. Samant, C. E, L. Grenier, S. Lowry
 
Vol 23, No 5 (2016) Painless neutropenic enterocolitis in a patient undergoing chemotherapy Abstract   PDF   HTML
E.J. Chow, K.D. Bishop
 
Vol 24, No 3 (2017) Palliative care as a public health issue: understanding disparities in access to palliative care for the homeless population living in Toronto, based on a policy analysis Abstract   PDF   HTML
B. Henry, N. Dosani, L. Huynh, N. Amirault
 
Vol 26, No 1 (2019) Palliative care consultation and aggressive care at end of life in unresectable pancreatic cancer Abstract   PDF   HTML
C. Lees, S. Weerasinghe, N. Lamond, T. Younis, Ravi Ramjeesingh
 
Vol 26, No 1 (2019) Palliative care for cancer patients near end of life in acute-care hospitals across Canada: a look at the inpatient palliative care code Abstract   PDF   HTML
J. Tung, J. Chadder, D. Dudgeon, C. Louzado, J. Niu, R. Rahal, A. Sinnarajah
 
Vol 22, No 5 (2015) Palliative chemotherapy for patients 70 years of age and older with metastatic colorectal cancer: a single-centre experience Abstract   PDF   HTML
D. Bossé, M. Vickers, F. Lemay, A. Beaudoin
 
Vol 23, No 3 (2016) Palliative chemotherapy in advanced colorectal cancer patients 80 years of age and older Abstract   PDF   HTML
P. Lai, S. Sud, T. Zhang, T. Asmis, P. Wheatley-Price
 
Vol 21, No 2 (2014) Palliative sedation— still a complex clinical issue! Abstract   PDF   HTML
R.L. Fainsinger
 
Vol 18, No 3 (2011) Pan-Canadian initiatives in colorectal cancer screening: adopting knowledge translation tools to accelerate uptake and impact Abstract   PDF   HTML
H. E. Bryant, S. V. Fekete, D. H. Major
 
2008: Presentations from the Integrating Wellness into Cancer Care Conference Panel Discussion 1 Abstract   PPT Presentation
S Sutcliffe, G. Deng, L. Wright, J. Maher, S. Sagar
 
2008: Presentations from the Integrating Wellness into Cancer Care Conference Panel Discussion 2 Abstract   PPT Presentation
M. Philp, G. Payne, A. Cunningham, M. Vachon
 
2008: Presentations from the Integrating Wellness into Cancer Care Conference Panel Discussion 3 Abstract   PPT Presentation
B. Bell, Terry Sullivan, M. Vachon, P. Catton, A. Jadad, L. Morrison
 
Vol 20, No 6 (2013) Panitumumab monotherapy compared with cetuximab and irinotecan combination therapy in patients with previously treated KRAS wild-type metastatic colorectal cancer Abstract   PDF   HTML
H. Kennecke, L. Chen, C.D. Blanke, W.Y. Cheung, K. Schaff, C. Speers
 
Vol 24, No 5 (2017) Papillary thyroid carcinoma in a boy with familial tuberous sclerosis complex attributable to a TSC2 deletion—a case report Abstract   PDF   HTML
M. Flader, P. Kurzawa, J. Maldyk, J. Sygut, J. Harasymczuk, A. Kropinska, D. Handkiewicz-Junak, B. Jarzab, K. Kotulska, M. Niedziela
 
Vol 22, No 6 (2015) Para-aortic and pelvic extended-field radiotherapy for advanced-stage uterine cancer: dosimetric and toxicity comparison between the four-field box and intensity-modulated techniques Abstract   PDF   HTML
A. Rabinovich, L. Bernard, A.V. Ramanakumar, G. Stroian, W.H. Gotlieb, S. Lau, B. Bahoric
 
Vol 25, No 5 (2018) Paroxysmal nocturnal hemoglobinuria testing in patients with myelodysplastic syndrome in clinical practice—frequency and indications Abstract   PDF   HTML
S. A. Wong, B. I. Dalal, H. A. Leitch
 
Vol 16, No 6 (2009) Partial cancerous changes eventually developing into superficial spreading cancer over 18 months Abstract   PDF
Y. Song, Z. Wang, Q. Tang, H. Xu, C. Xing, Z. Miao, C. Yang
 
Vol 17, No 1 (2010) Pathology re-review as an essential component of breast cancer management Abstract   PDF
C.G. Kleer
 
Vol 18 (2011): The Optimization of Hormonal Therapy in Early Breast Cancer Patient adherence to aromatase inhibitor treatment in the adjuvant setting Abstract   PDF   HTML
S. Verma, Y. Madarnas, S. Sehdev, G. Martin, J. Bajcar
 
Vol 15 (2008): Supplement - Integrative Oncology: A Canadian and International Perspective Patient Decision-Making about Complementary and Alternative Medicine (CAM) in Cancer Management: The Context and Process Abstract   PDF
Lynda G Balneaves
 
Vol 26, No 1 (2019) Patient indications for Mohs micrographic surgery: a clinical practice guideline Abstract   PDF   HTML
C. Murray, D. Sivajohanathan, T. P. Hanna, S. Bradshaw, N. Solish, B. Moran, R. Hekkenberg, A. C. Wei, T. Petrella
 
Vol 21, No 2 (2014) Patient perceptions of a comprehensive cancer navigation service Abstract   PDF   HTML
W. Hryniuk, R. Simpson, A. McGowan, P. Carter
 
Vol 19 (2012): Improving Patient Outcomes in Advanced Prostate Cancer Patient preference and the impact of decision-making aids on prostate cancer treatment choices and post-intervention regret Abstract   PDF   HTML
J. Aning, R.J. Wassersug, S.L. Goldenberg
 
Vol 21, No 2 (2014) Patient preferences for stopping tyrosine kinase inhibitors in chronic myeloid leukemia Abstract   PDF   HTML
D. Sanford, R. Kyle, A. Lazo–Langner, I. Chin–Yee, K. Howson–Jan, C. Hsia
 
Vol 22, No 4 (2015) Patient preferences for timing and access to radiation therapy Abstract   PDF   HTML
I.A. Olivotto, J. Soo, R.A. Olson, L. Rowe, J. French, B. Jensen, A. Pastuch, R. Halperin, P.T. Truong
 
Vol 22, No 3 (2015) Patient with inoperable pheochromocytoma Abstract   PDF   HTML
D. Brancíková, Z. Mechl, Z. Adam, E. Jandáková, Z. Pavlovský, V. Válek, Z. Andrašina
 
Vol 22, No 2 (2015) Patient-expressed perceptions of wait-time causes and wait-related satisfaction Abstract   PDF   HTML
M. Mathews, D. Ryan, D. Bulman
 
Vol 25, No 6 (2018) Patient-reported outcome measurement compared with professional judgment of cosmetic results after breast-conserving therapy Abstract   PDF   HTML
A.T.P.M. Brands-Appeldoorn, A.J.G. Maaskant-Braat, W.A.R Zwaans, J.P. Dieleman, K.E. Schenk, C.L. Broekhuysen, H. Weerdenburg, R. Daniels, V.C.G. Tjan-Heijnen, R.M.H. Roumen
 
Vol 25, No 6 (2018) Patients with advanced cancer: when, why, and how to refer to palliative care services Abstract   PDF   HTML
C. Courteau, G. Chaput, L. Musgrave, A. Khadoury
 
Vol 25, No 5 (2018) Patients with non-small-cell lung cancer harbouring a BRAF mutation: a multicentre study exploring clinical characteristics, management, and outcomes in a real-life setting: EXPLORE GFPC 02-14 Abstract   PDF   HTML
J. B. Auliac, S. Bayle, A. Vergnenegre, H. Le Caer, L. Falchero, R. Gervais, H. Doubre, F. Vinas, B. Marin, C. Chouaid
 
Vol 21, No 2 (2014) Patients’ perceptions of gene expression profiling in breast cancer treatment decisions Abstract   PDF   HTML
Y. Bombard, L. Rozmovits, M.E. Trudeau, N.B. Leighl, K. Deal, D.A. Marshall
 
Vol 24, No 6 (2017) Patterns of cancer centre follow-up care for survivors of breast, colorectal, gynecologic, and prostate cancer Abstract   PDF   HTML
R. Urquhart, L. Lethbridge, G.A. Porter
 
Vol 23, No 1 (2016) Patterns of care and treatment trends for Canadian men with localized low-risk prostate cancer: an analysis of provincial cancer registry data Abstract   PDF   HTML
K. Tran, R. Rahal, S. Fung, C. Louzado, G. Porter, J. Xu, H. Bryant
 
Vol 24, No 3 (2017) Patterns of failure in anaplastic and differentiated thyroid carcinoma treated with intensity-modulated radiotherapy Abstract   PDF   HTML
H. Vulpe, J.Y.Y. Kwan, A. McNiven, J.D. Brierley, R. Tsang, B. Chan, D.P. Goldstein, L.W. Le, A. Hope, M. Giuliani
 
Vol 20, No 5 (2013) Patterns of practice in the prescription of palliative radiotherapy for the treatment of bone metastases at the Rapid Response Radiotherapy Program between 2005 and 2012 Abstract   PDF   HTML
N. Thavarajah, L. Zhang, K. Wong, G. Bedard, E. Wong, M. Tsao, C. Danjoux, E. Barnes, A. Sahgal, K. Dennis, L. Holden, N. Lauzon, E. Chow
 
Vol 23, No 5 (2016) Patterns of practice with third-line anti-EGFR antibody for metastatic colorectal cancer Abstract   PDF   HTML
M.Y. Ho, D.J. Renouf, W.Y. Cheung, H.J. Lim, C.H. Speers, C. Zhou, H.F. Kennecke
 
Vol 18, No 6 (2011) Patterns of presentation, referral, and treatment of hepatocellular carcinoma in a pre-sorafenib era: experience of a Canadian provincial cancer agency Abstract   PDF   HTML
T. Sundaralingam, S. Gill
 
Vol 24, No 4 (2017) Patterns of spread and prognostic implications of lung cancer metastasis in an era of driver mutations Abstract   PDF   HTML
F. Hsu, A. De Caluwe, D. Anderson, A. Nichol, T. Toriumi, C. Ho
 
901 - 1000 of 1559 Items << < 5 6 7 8 9 10 11 12 13 14 > >>